Infectious diseases testing market includes the detection of diseases
caused by microorganisms such as fungi, bacteria, viruses, and
parasites are called infectious diseases. These infectious diseases are
transmitted from person to person through various routes such as
contaminated food, contaminated water, and oro-feacal route, among
others. Though there are vaccines to prevent few of the infectious
diseases, such as measles and chickenpox, not all infectious diseases
have vaccines. Hence it is very necessary to develop testing methods for
various infectious diseases. In addition, there have been a range of
new infectious diseases in the market which would contribute to the
growth of infectious diseases testing market. In addition, the recent
advances with the identification of nanoprobes and their utilization in
in-vitro diagnostics which lead to the effective detection of infectious
diseases through nanodiagnosis, which would revolutionize the
infectious diseases testing market. The various applications of
nanodiagnosis include identification of biomarkers, and diagnostics of
infectious diseases, among others. In infectious diseases testing
market, In vitro diagnostics are commonly employed for the detection of
infectious diseases, and these tests are performed in various samples,
such as blood, urine, serum, and saliva, among others.
Infectious diseases testing market can be segmented on the basis of
technology employed for the detection, product type, end user,
application, and geography. On the basis of test type, the infectious
diseases testing market can be segmented into Immunochemistry testing,
microbiology testing, and molecular diagnostics, among others.
Immunochemistry testing includes immunoassays such as enzyme linked
immunosorbant assay (ELISA), and chemiluminescence immunoassays. Product
type segmentation of the infectious diseases detection market can be
given as reagents, instruments and software. Infectious diseases
detection market can be segmented on the basis of application into
hepatitis, sexually transmitted diseases, syphilis, measles,
tuberculosis, and malaria, among others. The end users in the infectious
diseases detection market include hospitals, point of care centers and
diagnostic laboratories. On the basis of geography, infectious diseases
testing market has been segmented into North America, Latin America,
Europe, Asia Pacific, and Middle East and Africa.
The growing prevalence of infectious diseases, the continuous
mutations in the microorganisms leading to new strains, and the growing
rate of new infections contribute to the growth of the infectious
diseases testing market. In addition, the changing technology leading to
the development of tests with enhanced detection rate, growing
awareness among people contribute positively to the growth of infectious
diseases testing market. Growing awareness among people, increasing
government initiatives to improve the health profiles of the population
and growing geriatric population contribute to the growth in the
infectious diseases testing market. Furthermore, growing modes of
transmission of the disease such as various zoonotic modes, and the lack
of cleanliness in certain regions lead to the growth in the prevalence
of infectious diseases contributing to the growth of infectious diseases
testing market. However, asymptomatic conditions of infectious
diseases, lack of treatment for certain diseases, false positive results
with certain tests might hinder the growth of infectious diseases
testing market.
Based on the technology type, immunochemistry tests such as immunoassays are expected to dominate the infectious diseases testing market. In addition, the increasing demand for rapid tests, contribute to the growth of infectious diseases testing market. On the basis of product type, reagents that include molecular diagnostic kits and immunoassays employed in the detection of various infectious diseases dominated the infectious diseases testing market and are expected to grow further during the forecast period. On a regional basis, North America dominated to the infectious diseases testing market, owing to its advanced healthcare infrastructure, increased healthcare spending, and focus on development of other tests which give faster and accurate results. However, Asia Pacific is expected to grow at a highest CAGR in the infectious diseases testing market, during the forecast period, owing to the growing prevalence of infectious diseases and the growing government initiatives on enhancing the healthcare infrastructure.
The leading players in infectious diseases testing market include Abbott Laboratories, Alere, Inc., Becton Dickinson (BD) Company, Inc., bioMeriux SA, Bio-Rad Laboratories, Gen-Probe, Inc. (a part of Hologic, Inc.), LifeScan, Inc. (a Johnson & Johnson company), Luminex Corporation, Ortho-Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific.
Report Overview @ https://www.transparencymarketresearch.com/infectious-diseases-testing-market.html
Based on the technology type, immunochemistry tests such as immunoassays are expected to dominate the infectious diseases testing market. In addition, the increasing demand for rapid tests, contribute to the growth of infectious diseases testing market. On the basis of product type, reagents that include molecular diagnostic kits and immunoassays employed in the detection of various infectious diseases dominated the infectious diseases testing market and are expected to grow further during the forecast period. On a regional basis, North America dominated to the infectious diseases testing market, owing to its advanced healthcare infrastructure, increased healthcare spending, and focus on development of other tests which give faster and accurate results. However, Asia Pacific is expected to grow at a highest CAGR in the infectious diseases testing market, during the forecast period, owing to the growing prevalence of infectious diseases and the growing government initiatives on enhancing the healthcare infrastructure.
The leading players in infectious diseases testing market include Abbott Laboratories, Alere, Inc., Becton Dickinson (BD) Company, Inc., bioMeriux SA, Bio-Rad Laboratories, Gen-Probe, Inc. (a part of Hologic, Inc.), LifeScan, Inc. (a Johnson & Johnson company), Luminex Corporation, Ortho-Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific.
No comments:
Post a Comment